WorksheetsNCM 106
Total questions: 58
Worksheet time: 37mins
official or non-proprietary name ; universally accepted
Generic name
Brand (trade) name
Chemical name
chemicals that are introduced into the body to cause some sort of change
(a)
study of substances that interact with the living systems through chemical processes, by binding to regulatory molecules & activating or inhibiting normal body processes
Pharmacotherapeutics (Clinical Pharmacology)
Pharmacology
Drug study
Pharmacist
compilation of the package insert information from drugs used in this country, along with some drug advertising
Drug labels
Physician’s Drug Reference (PDR)
Package insert
Reference books
available form (tablet/ capsule/ syrup/ suspension, etc.)
(a)
proprietary name ; registered trademark owned by that specific manufacturer that developed it
Generic name
Brand (trade) name
Chemical name
dose available in the product
(a)
chemicals that are produced by companies involved solely in the manufacturing of drugs
Orphan drugs
Generic drugs
Over-the-counter (OTC) drugs
specific batch from which the drug was produced; important for recall information
(a)
have specific information that identifies a specific drug
Drug labels
Physician’s Drug Reference (PDR)
Package insert
Reference books
pharmaceutical company that produces the drug
(a)
for drug information
Drug labels
Physician’s Drug Reference (PDR)
Package insert
Reference books
name that reflects the chemical structure of a drug
Generic name
Brand (trade) name
Chemical name
indicates date after which the drug should be used
(a)
drugs that have been discovered but are not financially viable and therefore have not been "adopted" by any drug company because they have limited market or a narrow margin of safety
Orphan drugs
Generic drugs
Over-the-counter (OTC) drugs
branch of pharmaceutical that uses drugs to treat, prevent, and diagnose disease ; addresses two key concerns: the drug's effects on the body, and the body's response to the drug
Pharmacotherapeutics (Clinical Pharmacology)
Pharmacology
Drug study
Pharmacist
an agency responsible for the regulation and enforcement of drug evaluation and distribution policies
DEA (Drug Inforcement Agency)
PDEA (Philippine Drug Enforcement Agency)
FDA (Food and Drug Administration)
DDB (Dangerous Drugs Board)
contains all of the chemical and study information that led to the drug's approval
Drug labels
Physician’s Drug Reference (PDR)
Package insert
Reference books
drugs with abuse potential
(a)
products that are available without prescription for self-treatment of a variety of complaints
Orphan drugs
Generic drugs
Over-the-counter (OTC) drugs
used to treat cardiac disorders
various opiates (poppy)
digitalis (foxglove)
dronabinol (marinol)
substance made by chemical synthesis to imitate a natural product
(a)
used to replace human chemicals that fail to be produced because of disease or genetic problems
(a)
used for sedation are still derived from plants
various opiates (poppy)
digitalis (foxglove)
dronabinol (marinol)
growth hormone preparations ; obtained from animal thyroid and hypothalamic tissues.
(a)
various chemical elements can have therapeutic effects in the human body
(a)
contains the active ingredient delta-9-tetrahydrocannabinol found in marijuana ; helps to prevent nausea and vomiting in cancer patients
various opiates (poppy)
digitalis (foxglove)
dronabinol (marinol)
for treating diabetes ; obtained exclusively from the pancreas of cows and pigs.
(a)
used as medicines since prehistoric times
(a)
measure of the amount of drug necessary to produce an effect of a given magnitude
(a)
receptor in the cell nucleus ; activation through transcription
kinase-linked
ligand-gated ion channels
G-protein coupled receptor
Nuclear receptor
narrow margin of safety
Low Therapeutic Index
High Therapeutic Index
margin of safety ; the dose of the drug required to produce a desired effect to that which produces undesired effects
Dose response
Pharmacodynamics
Therapeutic Index
drug spans the cell membrane and opens the channel allowing ions to flow into and out of the cell (Na and Ca)
kinase-linked
ligand-gated ion channels
G-protein coupled receptor
Nuclear receptor
as the concentration of a drug increases, its pharmacologic effect also gradually increases until all receptors are occupied and further increase in dose no further increase its effect
Quantal dose response
Graded dose response
wide margin of safety
Low Therapeutic Index
High Therapeutic Index
More severe than side effects and are always undesirable
Side effects
Toxic effects
Adverse effects
drugs bind onto a cell surface
kinase-linked
ligand-gated ion channels
G-protein coupled receptor
Nuclear receptor
interactions between the chemical components of living systems and the foreign chemicals, including drugs, that enter those systems
Dose response
Pharmacodynamics
Therapeutic Index
mostly proteins ; drugs bind to receptors to activate or inhibit response
(a)
drug toxicity (dangerous) ; when the drug exceeds the therapeutic range or drug accumulation ; are not acceptable adverse effects but are potentially serious reactions to a drug
Side effects
Toxic effects
Adverse effects
certain pharmacological effects which can not be quantified but can only be said to be present or absent (all or none)
Quantal dose response
Graded dose response
the relationship between the minimal vs. the maximal amount of drug dose needed to produce the desired drug response
Dose response
Pharmacodynamics
Therapeutic Index
ability of the drug to elicit a response when it interacts with a receptor
(a)
G-protein binds w/ GTP → enzyme or ion channel
kinase-linked
ligand-gated ion channels
G-protein coupled receptor
Nuclear receptor
drugs that simulate or blocks the cholinergic receptors and affects all anatomic sites of location
Non-specific drugs
Antagonist
Narrow therapeutic window
Non-selective drugs
are physiologic effects not related to desired drug effects (desirable/undesirable)
Side effects
Toxic effects
Adverse effects
more toxic
Non-specific drugs
Antagonist
Narrow therapeutic window
Wide therapeutic window
the highest plasma concentration of drug at a specific time
Peak Drug Level
Therapeutic Range (Therapeutic Window)
Loading Dose
drugs that block a response
Non-specific drugs
Antagonist
Narrow therapeutic window
Agonist
a large initial dose to achieve a rapid minimum effective concentration in the plasma
Peak Drug Level
Therapeutic Range (Therapeutic Window)
Loading Dose
drugs that produce a response
Agonist
Wide therapeutic window
Non-selective drugs
Antagonist
occurs when the drug reaches its highest blood or plasma concentration
Duration of Action
Peak Action
Onset of Action
the length of time the drug has a pharmacologic effect
Duration of Action
Peak Action
Onset of Action
drugs acting on different receptors
Agonist
Wide therapeutic window
Non-selective drugs
Non-specific drugs
less toxic
Agonist
Wide therapeutic window
Non-selective drugs
Narrow therapeutic window
conc. of the drug in the plasma should be between the minimum effective concentration and the minimum toxic conc. (toxic effect)
Peak Drug Level
Therapeutic Range (Therapeutic Window)
Loading Dose
the time it takes to reach the minimum effective concentration (MEC) after the drug is administered
Duration of Action
Peak Action
Onset of Action
